Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept versus adalimumab for rheumatoid arthritis pain
2019-004468-23Phase 4Unknown
- Sponsor
- St George's, University of London
- Start
- Feb 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of abatacept and adalimumab in rheumatoid arthritis (RA) (2 arms), sponsored by St George's, University of London. Status: unknown.
02
Drugs
abataceptadalimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2019-004468-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004468-23.